[1]
Thun MJ, DeLancey JO, Center MM, Jemal A, Ward EM. The global burden of cancer: priorities for prevention. Carcinogenesis. 2010 Jan:31(1):100-10. doi: 10.1093/carcin/bgp263. Epub 2009 Nov 24
[PubMed PMID: 19934210]
[2]
Hayes NS, Hohman K, Vinson C, Pratt-Chapman M. Comprehensive cancer control in the U.S.: summarizing twenty years of progress and looking ahead. Cancer causes & control : CCC. 2018 Dec:29(12):1305-1309. doi: 10.1007/s10552-018-1124-y. Epub 2018 Dec 19
[PubMed PMID: 30569331]
[3]
Barton MB, Jacob S, Shafiq J, Wong K, Thompson SR, Hanna TP, Delaney GP. Estimating the demand for radiotherapy from the evidence: a review of changes from 2003 to 2012. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2014 Jul:112(1):140-4. doi: 10.1016/j.radonc.2014.03.024. Epub 2014 May 12
[PubMed PMID: 24833561]
[4]
Dörr W, Hendry JH. Consequential late effects in normal tissues. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2001 Dec:61(3):223-31
[PubMed PMID: 11730991]
[5]
Dewey WC, Furman SC, Miller HH. Comparison of lethality and chromosomal damage induced by x-rays in synchronized Chinese hamster cells in vitro. Radiation research. 1970 Sep:43(3):561-81
[PubMed PMID: 5466865]
[6]
Hendry JH, West CM. Apoptosis and mitotic cell death: their relative contributions to normal-tissue and tumour radiation response. International journal of radiation biology. 1997 Jun:71(6):709-19
[PubMed PMID: 9246185]
[7]
Steel GG. The case against apoptosis. Acta oncologica (Stockholm, Sweden). 2001:40(8):968-75
[PubMed PMID: 11845962]
Level 3 (low-level) evidence
[8]
Chen Y, Williams J, Ding I, Hernady E, Liu W, Smudzin T, Finkelstein JN, Rubin P, Okunieff P. Radiation pneumonitis and early circulatory cytokine markers. Seminars in radiation oncology. 2002 Jan:12(1 Suppl 1):26-33
[PubMed PMID: 11917281]
[9]
Rubin P, Johnston CJ, Williams JP, McDonald S, Finkelstein JN. A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis. International journal of radiation oncology, biology, physics. 1995 Aug 30:33(1):99-109
[PubMed PMID: 7642437]
[10]
Coderre JA, Morris GM, Micca PL, Hopewell JW, Verhagen I, Kleiboer BJ, van der Kogel AJ. Late effects of radiation on the central nervous system: role of vascular endothelial damage and glial stem cell survival. Radiation research. 2006 Sep:166(3):495-503
[PubMed PMID: 16953668]
[11]
Stone HB, Coleman CN, Anscher MS, McBride WH. Effects of radiation on normal tissue: consequences and mechanisms. The Lancet. Oncology. 2003 Sep:4(9):529-36
[PubMed PMID: 12965273]
[12]
Mohanti BK, Bansal M. Late sequelae of radiotherapy in adults. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2005 Oct:13(10):775-80
[PubMed PMID: 16041503]
[13]
Hall EJ. Intensity-modulated radiation therapy, protons, and the risk of second cancers. International journal of radiation oncology, biology, physics. 2006 May 1:65(1):1-7
[PubMed PMID: 16618572]
[14]
Dörr W, Hamilton CS, Boyd T, Reed B, Denham JW. Radiation-induced changes in cellularity and proliferation in human oral mucosa. International journal of radiation oncology, biology, physics. 2002 Mar 15:52(4):911-7
[PubMed PMID: 11958883]
[15]
Cooper JS, Fu K, Marks J, Silverman S. Late effects of radiation therapy in the head and neck region. International journal of radiation oncology, biology, physics. 1995 Mar 30:31(5):1141-64
[PubMed PMID: 7713779]
[16]
Mehta P, Fahlbusch FB, Rades D, Schmid SM, Gebauer J, Janssen S. Are hypothalamic- pituitary (HP) axis deficiencies after whole brain radiotherapy (WBRT) of relevance for adult cancer patients? - a systematic review of the literature. BMC cancer. 2019 Dec 12:19(1):1213. doi: 10.1186/s12885-019-6431-5. Epub 2019 Dec 12
[PubMed PMID: 31830931]
Level 1 (high-level) evidence
[17]
Cayuela N, Jaramillo-Jiménez E, Càmara E, Majós C, Vidal N, Lucas A, Gil-Gil M, Graus F, Bruna J, Simó M. Cognitive and brain structural changes in long-term oligodendroglial tumor survivors. Neuro-oncology. 2019 Nov 4:21(11):1470-1479. doi: 10.1093/neuonc/noz130. Epub
[PubMed PMID: 31549152]
[18]
Mikami T, Kato I, Nozaki F, Umeda K, Kamitori T, Tasaka K, Ogata H, Hiramatsu H, Arakawa Y, Adachi S. Sudden spinal hemorrhage in a pediatric case with total body irradiation-induced cavernous hemangioma. Pediatric blood & cancer. 2018 Oct:65(10):e27250. doi: 10.1002/pbc.27250. Epub 2018 May 24
[PubMed PMID: 29797651]
Level 3 (low-level) evidence
[19]
Wong CS, Fehlings MG, Sahgal A. Pathobiology of radiation myelopathy and strategies to mitigate injury. Spinal cord. 2015 Aug:53(8):574-80. doi: 10.1038/sc.2015.43. Epub 2015 Mar 24
[PubMed PMID: 25800695]
[20]
Chamberlain MC, Eaton KD, Fink J. Radiation-induced myelopathy: treatment with bevacizumab. Archives of neurology. 2011 Dec:68(12):1608-9. doi: 10.1001/archneurol.2011.621. Epub
[PubMed PMID: 22159063]
[21]
Morgan GW, Breit SN. Radiation and the lung: a reevaluation of the mechanisms mediating pulmonary injury. International journal of radiation oncology, biology, physics. 1995 Jan 15:31(2):361-9
[PubMed PMID: 7836090]
[22]
McDonald S, Rubin P, Phillips TL, Marks LB. Injury to the lung from cancer therapy: clinical syndromes, measurable endpoints, and potential scoring systems. International journal of radiation oncology, biology, physics. 1995 Mar 30:31(5):1187-203
[PubMed PMID: 7713782]
[23]
Adams MJ, Hardenbergh PH, Constine LS, Lipshultz SE. Radiation-associated cardiovascular disease. Critical reviews in oncology/hematology. 2003 Jan:45(1):55-75
[PubMed PMID: 12482572]
[24]
Taylor C, McGale P, Brønnum D, Correa C, Cutter D, Duane FK, Gigante B, Jensen MB, Lorenzen E, Rahimi K, Wang Z, Darby SC, Hall P, Ewertz M. Cardiac Structure Injury After Radiotherapy for Breast Cancer: Cross-Sectional Study With Individual Patient Data. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2018 Aug 1:36(22):2288-2296. doi: 10.1200/JCO.2017.77.6351. Epub 2018 May 23
[PubMed PMID: 29791285]
Level 2 (mid-level) evidence
[25]
Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Brønnum D, Correa C, Cutter D, Gagliardi G, Gigante B, Jensen MB, Nisbet A, Peto R, Rahimi K, Taylor C, Hall P. Risk of ischemic heart disease in women after radiotherapy for breast cancer. The New England journal of medicine. 2013 Mar 14:368(11):987-98. doi: 10.1056/NEJMoa1209825. Epub
[PubMed PMID: 23484825]
[26]
Darby S, McGale P, Peto R, Granath F, Hall P, Ekbom A. Mortality from cardiovascular disease more than 10 years after radiotherapy for breast cancer: nationwide cohort study of 90 000 Swedish women. BMJ (Clinical research ed.). 2003 Feb 1:326(7383):256-7
[PubMed PMID: 12560277]
[27]
O'Brien PC. Radiation injury of the rectum. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2001 Jul:60(1):1-14
[PubMed PMID: 11410298]
[28]
Zwaans BMM, Lamb LE, Bartolone S, Nicolai HE, Chancellor MB, Klaudia SW. Cancer survivorship issues with radiation and hemorrhagic cystitis in gynecological malignancies. International urology and nephrology. 2018 Oct:50(10):1745-1751. doi: 10.1007/s11255-018-1970-2. Epub 2018 Aug 21
[PubMed PMID: 30132277]
Level 2 (mid-level) evidence
[29]
Williams JA Jr, Clarke D, Dennis WA, Dennis EJ 3rd, Smith ST. The treatment of pelvic soft tissue radiation necrosis with hyperbaric oxygen. American journal of obstetrics and gynecology. 1992 Aug:167(2):412-5; discussion 415-6
[PubMed PMID: 1497044]
[30]
Kilgore LJ, Korentager SS, Hangge AN, Amin AL, Balanoff CR, Larson KE, Mitchell MP, Chen JG, Burgen E, Khan QJ, O'Dea AP, Nye L, Sharma P, Wagner JL. Reducing Breast Cancer-Related Lymphedema (BCRL) Through Prospective Surveillance Monitoring Using Bioimpedance Spectroscopy (BIS) and Patient Directed Self-Interventions. Annals of surgical oncology. 2018 Oct:25(10):2948-2952. doi: 10.1245/s10434-018-6601-8. Epub 2018 Jul 9
[PubMed PMID: 29987599]
[31]
Executive Committee of the International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: 2020 Consensus Document of the International Society of Lymphology. Lymphology. 2020:53(1):3-19
[PubMed PMID: 32521126]
Level 3 (low-level) evidence
[32]
Hoskin P. The price of anticancer intervention. Secondary malignancies after radiotherapy. The Lancet. Oncology. 2002 Sep:3(9):577-8
[PubMed PMID: 12233734]
[33]
Bentzen SM, Heeren G, Cottier B, Slotman B, Glimelius B, Lievens Y, van den Bogaert W. Towards evidence-based guidelines for radiotherapy infrastructure and staffing needs in Europe: the ESTRO QUARTS project. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2005 Jun:75(3):355-65
[PubMed PMID: 16086915]
Level 1 (high-level) evidence
[34]
O'Gorman C, Sasiadek W, Denieffe S, Gooney M. Predicting radiotherapy-related clinical toxicities in cancer: a literature review. Clinical journal of oncology nursing. 2014 Jun:18(3):E37-44. doi: 10.1188/14.CJON.E37-E44. Epub
[PubMed PMID: 24867122]
[35]
Krause M, Dubrovska A, Linge A, Baumann M. Cancer stem cells: Radioresistance, prediction of radiotherapy outcome and specific targets for combined treatments. Advanced drug delivery reviews. 2017 Jan 15:109():63-73. doi: 10.1016/j.addr.2016.02.002. Epub 2016 Feb 12
[PubMed PMID: 26877102]
[36]
Linge A, Löck S, Gudziol V, Nowak A, Lohaus F, von Neubeck C, Jütz M, Abdollahi A, Debus J, Tinhofer I, Budach V, Sak A, Stuschke M, Balermpas P, Rödel C, Avlar M, Grosu AL, Bayer C, Belka C, Pigorsch S, Combs SE, Welz S, Zips D, Buchholz F, Aust DE, Baretton GB, Thames HD, Dubrovska A, Alsner J, Overgaard J, Baumann M, Krause M, DKTK-ROG. Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(-) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROG. Clinical cancer research : an official journal of the American Association for Cancer Research. 2016 Jun 1:22(11):2639-49. doi: 10.1158/1078-0432.CCR-15-1990. Epub 2016 Jan 11
[PubMed PMID: 26755529]
Level 2 (mid-level) evidence
[37]
Kraus-Tiefenbacher U, Sfintizky A, Welzel G, Simeonova A, Sperk E, Siebenlist K, Mai S, Wenz F. Factors of influence on acute skin toxicity of breast cancer patients treated with standard three-dimensional conformal radiotherapy (3D-CRT) after breast conserving surgery (BCS). Radiation oncology (London, England). 2012 Dec 18:7():217. doi: 10.1186/1748-717X-7-217. Epub 2012 Dec 18
[PubMed PMID: 23249653]
[38]
Check DK, Chawla N, Kwan ML, Pinheiro L, Roh JM, Ergas IJ, Stewart AL, Kolevska T, Ambrosone C, Kushi LH. Understanding racial/ethnic differences in breast cancer-related physical well-being: the role of patient-provider interactions. Breast cancer research and treatment. 2018 Aug:170(3):593-603. doi: 10.1007/s10549-018-4776-0. Epub 2018 Apr 5
[PubMed PMID: 29623576]
Level 3 (low-level) evidence